Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Thomvest can afford a big loss

<< Previous

Bullboard Posts

Next >>

Comment by Thesweethearton Nov 14, 2019 9:25pm

61 Views

Post# 30354056

RE:Thomvest can afford a big loss

GunnerG wrote: Retail investors sometimes just cannot take a huge risk that this offers.

To the Thomson's this could go to zero and would have no affect on their lives at all.

I beg to differ, this will have huge affect of TV, when the company goes bankrupt TV will have a huge capital loss!!!! Then in 2020 SA sells pbi4050 for 200 mil.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market